Heparin process. I am having a hard time posting it so maybe for your own info you might want to try to find it. I will continue to try to post it as soon as I can free up more time. Tlsmd
Mylan and Teva rise on report about Amazon's pharmacy aims
1 hour 24 minutes ago - DJNF
By Emily Bary
Pharmacy-benefit managers and drugstores shares fall as they are viewed as vulnerable to Amazon's aims
Shares of generic drug manufacturers rose Friday following a report Amazon.com Inc. has held conversations with Mylan NV and Sandoz, a Novartis AG unit, about potentially entering the pharmacy market.
Meanwhile, drugstores, pharmacy-benefit managers, and distributors are seeing their stocks fall amid concerns that Amazon will provide new competition and disrupt their business models.
CNBC reported late Thursday (https://www.cnbc.com/2017/11/30/amazon-holding-exploratory-talks-with-generic-drug-makers.html) that the Mylan and Sandoz have engaged in "high level" talks and added that it is still unclear what Amazon's(AMZN) pharmacy ambitions are.
"This means that Amazon may be simultaneously exploring either opening a retail pharmacy or drug distribution business," analyst Brian Nowak at Morgan Stanley wrote in a note to clients.
He said the next potential signposts to watch for are Amazon opening a pharmacy inside a Whole Foods Market store and a filing for pharmacy and drug licenses.
Don't miss: Amazon's getting into the pharmacy business is a 'matter of when, not if.' (http://www.marketwatch.com/story/amazons-getting-into-the-pharmacy-business-is-a-matter-of-when-not-if-2017-10-06)
(http://www.marketwatch.com/story/amazons-getting-into-the-pharmacy-business-is-a-matter-of-when-not-if-2017-10-06)Also read: Amazon wants to disrupt the neighborhood pharmacy--but its sketchy health products could get in the way (http://www.marketwatch.com/story/amazons-sketchy-health-products-could-hurt-its-big-pharmacy-ambitions-2017-11-20).
Mylan's(MYL) stock shot up 5.0% in midday trade, while Novartis'(NOVN.EB) shares edged up 0.2%.
Among others in the generic drug business, shares of Teva Pharmaceutical Industries(TEVA) hiked up 4.6% and Endo International(ENDP)(ENDP)(ENDP) ran up 3.3%.
Among drugstore chains, shares of Rite Aid Corp.(RAD) slumped 4.2%, Walgreens Boots Alliance(WBA)shed 2.1% and CVS Health Corp.(CVS) dropped 2.0%.
Shares of distributors also fell, as McKesson Corp.(MCK) down 1.1%, Amerisource Bergen Corp.(ABC) slid 0.9% and Cardinal Health Inc.(CAH)gave up 0.5%.
Pharmacy-benefit manager Express Scripts (ESRX) is considered by some to be a potential partner for Amazon (http://www.marketwatch.com/story/amazons-getting-into-the-pharmacy-business-is-a-matter-of-when-not-if-2017-10-06), but its stock was down 1.2%.
"The economics around generic drugs are unique within the supply chain and might make them more attractive for Amazon than trying to sell other brand or specialty drugs where prices are set and then negotiated by pharmacy-benefit managers," wrote Needham analyst Kevin Caliendo in a note to clients. He added that Amazon "still likely will need to acquire a mail order pharmacy or small pharmacy benefit manager to get the licenses needed to distribute and/or dispense drugs on a state-by-state basis."
Amazon's stock fell 1.4% Friday. It was still up 55% so far in 2017, compared with an 18 % gain for the S&P 500 index .
-Emily Bary; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
December 01, 2017 13:32 ET (18:32 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Recent VTRS News
- Viatris Announces the Pricing Terms of Maximum Tender Offer • PR Newswire (US) • 09/18/2024 03:30:00 PM
- Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer • PR Newswire (US) • 09/18/2024 12:45:00 AM
- Viatris to Report Third Quarter 2024 Financial Results on November 7, 2024 • PR Newswire (US) • 09/16/2024 08:30:00 PM
- Viatris Announces Expiration and Results of Any and All Cash Tender Offers • PR Newswire (US) • 09/10/2024 11:00:00 PM
- Viatris Announces the Pricing Terms of Pending Any and All Cash Tender Offers • PR Newswire (US) • 09/10/2024 03:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/04/2024 11:46:56 AM
- Viatris Announces Cash Tender Offers for Certain Outstanding Notes • PR Newswire (US) • 09/04/2024 07:30:00 AM
- Viatris Presents Late Breaking Abstract on Cenerimod at the 26th Asia-Pacific League of Associations for Rheumatology Annual Congress • PR Newswire (US) • 08/23/2024 10:59:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:03:07 PM
- Viatris Reports Second Quarter Financial Results for 2024 • PR Newswire (US) • 08/08/2024 10:59:00 AM
- Viatris Announces Second Quarter 2024 Dividend • PR Newswire (US) • 08/06/2024 10:59:00 AM
- Google Faces Antitrust Ruling; SunPower Files for Bankruptcy and Business Sale – Latest Business News • IH Market News • 08/06/2024 09:44:42 AM
- Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture • PR Newswire (US) • 07/03/2024 12:30:00 PM
- U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation • PR Newswire (US) • 07/02/2024 11:30:00 AM
- Viatris Named to TIME's World's Most Sustainable Companies 2024 List • PR Newswire (US) • 06/25/2024 03:00:00 PM
- Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024 • PR Newswire (US) • 06/07/2024 10:59:00 AM
- Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • PR Newswire (US) • 06/04/2024 10:59:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 11:16:03 AM
- Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors • PR Newswire (US) • 06/03/2024 10:59:00 AM
- Viatris to Participate in the Jeffries Global Healthcare Conference • PR Newswire (US) • 05/31/2024 10:59:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2024 10:00:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/28/2024 08:04:09 PM
- Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale • PR Newswire (US) • 05/21/2024 10:59:00 AM
- U.S. Index Futures Dip, Bank of England Holds Interest Rates at 5.25% • IH Market News • 05/09/2024 11:47:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:44:13 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM